Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Glioma × Speech Therapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Tongue Neoplasms 1 Mouth Neoplasms 1 Head and Neck Neoplasms 1 Glioma 1 Communication Disorders 1

Interventions

Magnetic Resonance Spectroscopy 15 Blood Specimen Collection 7 Temozolomide 5 Yoga 3 Radiotherapy, Intensity-Modulated 3 Magnetic Resonance Imaging 3 Biopsy 3 Bevacizumab 3 Transcranial Magnetic Stimulation 2 Surveys and Questionnaires 2 Restraint, Physical 2 Radiosurgery 2 Radiation 2 Psychosocial Intervention 2 Proton Therapy 2 Physical Therapy Modalities 2 Palliative Care 2 Mind-Body Therapies 2 Mental Status and Dementia Tests 2 Heart Rate 2 Gadolinium DTPA 2 Exercise 2 Elasticity Imaging Techniques 2 Drug Therapy 2 Diffusion Tensor Imaging 2 Congresses as Topic 2 Aminolevulinic Acid 2 poly ICLC 1 pembrolizumab 1 gallium Ga 68 dotatate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05189366 2025-10-07

SOPHNEURO

Institut Cancerologie de l'Ouest

Phase NA Terminated

Communication Disorders, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡